Oral kontraseptif kullanan hastada miyokard enfarktüsü gelişimi ve trombofili tanısı

Genç kadınlarda oral kontraseptif ilaçlar venöz tromboemboli, miyokard enfarktüsü ve serebrovasküler hastalık riskini arttırmaktadır. Özellikle trombofilisi olan hastalarda risk daha da artmaktadır. Biz makalemizde oral kontraseptif kullanan ve trombofilisi olan miyokard enfarktüsü ile başvurmuş vakamızı sunacağız.

Myocardial infarction in a patient using oral contraceptives and diagnosis of thrombophilia

In young women oral contraceptive drugs increase venous thromboembolism, myocardial infarction and cerebrovascular disease risk. Especially in patients with thrombophilia, the risk increases even more. We will present our case in our article with oral contraceptive and myocardial infarction with thrombophilia.

Kaynakça

De Moerloose P, Boehlen F. Inherited thrombophilia in arterial disease: a selective review. Semin Hematol 2007;44:106-113.

Evangelou D, Letsas KP, Korantzopoulos P, Antonellis I, Sioras E, Kardaras F. Spontaneous coronary artery dissection associated with oral contraceptive use: a case reportand review of the literature. Int J Cardiol 2006;112:380-382.

Alihanoğlu YI, Alur İ, Yıldız BS, Esin F, Bilge A. Acute myocardial infarction in a young female patient using oral contraceptives possessing a factor V leiden mutation. JAEMCR 2013;4:106-108.

Gong LL, Peng JH, Han FF, et al. Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.Thromb Res 2012;130:43-51.

Kim RJ, BeckerRC. Association between factor V Leiden, prothrombin G20210A, and methylene tetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J 2003;146:948-957.

Nizankowska-Mogilnicka E, Adamek L, Grzanka P, et al. Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis. Eur Respir J 2003;21:25-30.

Shapiro S, Slone D, Rosenberg L, Kaufman DW, Stolley PD, Miettinen OS. Oral-contraceptive use in relation to myocardial infarction. Lancet 1979;1:743-747.

World Health Organization. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study: WHO collaborative study of cardiovascular disease and steroid hormone contraception. Lancet 1997;349:1202- 1209.

Stegeman BH, De Bastos M, Rosendaal FR, et al. Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis. BMJ 2013;347:5298.

Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Oral contraceptives, hormone replacement therapy and thrombosis. Thromb Haemost 2001;86:112-123.

Rosendaal FR, Van HylckamaVlieg A, Tanis BC, Helmerhorst FM. Estrogens, progestogens and thrombosis. J Thromb Haemost 2003;1:1371-1380.

S. Middeldorp, J.C. Meijers, A.E. van den Ende, et al. Effects on coagulation of levonorgestrel-and desogestrel-containing low dose oral contraceptives: a cross-overstudy. Thromb Haemost 2000;84;4-8.

Boyce J, Fawcett JW, Noall EWP. Coronary thrombosis and conovid. Lancet 1963;1:111.

Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ. Atherothrombosis and high risk plaque: part I: evolving concepts. J Am Coll Cardiol 2005;46:937-954.

Kaynak Göster